About: Designer Anabolic Steroid Control Act of 2014

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Designer Anabolic Steroid Control Act of 2014 Goto Sponge NotDistinct Permalink

An Entity of Type : dbo:Person, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FDesigner_Anabolic_Steroid_Control_Act_of_2014&graph=http%3A%2F%2Fdbpedia.org&graph=http%3A%2F%2Fdbpedia.org

The Designer Anabolic Steroid Control Act of 2014 (H.R. 4771) is a bill that expanded the list of anabolic steroids regulated by the Drug Enforcement Administration (DEA) to include about two dozen new substances and established new crimes relating to false labeling of steroids. The bill established a penalty of up to $500,000 against those found to be falsely labeling their anabolic steroid products. The bill was introduced into the United States House of Representatives during the 113th United States Congress. The President signed the bill into law on December 18, 2014.

Attributes	Values
rdf:type	person
rdfs:label	Designer Anabolic Steroid Control Act of 2014 (en)
rdfs:comment	The Designer Anabolic Steroid Control Act of 2014 (H.R. 4771) is a bill that expanded the list of anabolic steroids regulated by the Drug Enforcement Administration (DEA) to include about two dozen new substances and established new crimes relating to false labeling of steroids. The bill established a penalty of up to $500,000 against those found to be falsely labeling their anabolic steroid products. The bill was introduced into the United States House of Representatives during the 113th United States Congress. The President signed the bill into law on December 18, 2014. (en)
name	Designer Anabolic Steroid Control Act of 2014 (en)
dcterms:subject	Acts of the 113th United States Congress
Wikipage page ID	43808354 (xsd:integer)
Wikipage revision ID	1077031605 (xsd:integer)
Link from a Wikipage to another Wikipage	Cancer American College of Sports Medicine Puberty List of bills in the 113th United States Congress Bodybuilding Department of Health and Human Services United States Attorney General United States Department of Justice United States House of Representatives 113th United States Congress Congressional Budget Office Controlled Substances Act Chemical nomenclature Low-density lipoprotein Crime Victims Fund Labelling Left ventricle Anabolic steroids Steroid Joseph R. Pitts Performance-enhancing drugs Public domain House Committee on the Judiciary Barack Obama Acts of the 113th United States Congress United States House Energy Subcommittee on Health AIDS Acne vulgaris Drug Enforcement Administration Ergogenic aid Federal Food, Drug, and Cosmetic Act Food and Drug Administration United States House Committee on the Judiciary Gynecomastia High blood pressure International Union of Pure and Applied Chemistry Council for Responsible Nutrition dbr:Testosterone dbr:Cholesterol Black market Hepatotoxicity Herb High-density lipoprotein Controlled substances IOC Voice vote Testicular atrophy PAYGO Skeletal muscle United States House Committee on Energy and Commerce United States House Judiciary Subcommittee on Crime, Terrorism, Homeland Security and Investigations Wasting Counterfeit drugs Donna Christensen House Committee on Energy and Commerce Use of performance-enhancing drugs in sport Unfunded Mandates Reform Act dbr:United_Natural_Products_Alliance
Link from a Wikipage to an external page	http://www.cbo.gov/publication/45595 http://www.opencongress.org/bill/hr4771-113/show https://beta.congress.gov/bill/113th-congress/house-bill/4771 https://washingtonwatch.com/bills/show/113_HR_4771.html http://hdl.loc.gov/loc.uscongress/legislation.113hr4771 https://www.govtrack.us/congress/bills/113/hr4771
sameAs	Designer Anabolic Steroid Control Act of 2014 Designer Anabolic Steroid Control Act of 2014 Designer Anabolic Steroid Control Act of 2014 Designer Anabolic Steroid Control Act of 2014
sponsored by	Joseph R. Pitts
dbp:wikiPageUsesTemplate	dbt:Infobox_United_States_federal_proposed_legislation dbt:Main dbt:Reflist dbt:USBill dbt:USC dbt:Wikisource dbt:US_government_sources
introducedby	Joseph R. Pitts
introduceddate	2014-05-29 (xsd:date)
introducedin	House (en)
passedbody	House (en) Senate (en)
passeddate	2014-09-15 (xsd:date) 2014-12-11 (xsd:date)
passedvote	Voice vote
signeddate	2014-12-18 (xsd:date)
signedpresident	Barack Obama
committees	House Committee on the Judiciary United States House Judiciary Subcommittee on Crime, Terrorism, Homeland Security and Investigations House Committee on Energy and Commerce
fullname	To amend the Controlled Substances Act to more effectively regulate anabolic steroids. (en)
has abstract	The Designer Anabolic Steroid Control Act of 2014 (H.R. 4771) is a bill that expanded the list of anabolic steroids regulated by the Drug Enforcement Administration (DEA) to include about two dozen new substances and established new crimes relating to false labeling of steroids. The bill established a penalty of up to $500,000 against those found to be falsely labeling their anabolic steroid products. Specifically, the text of the bill reads: "In the case of a violation...by an importer, exporter, manufacturer, or distributor...up to $500,000 per violation...For purposes of this subparagraph, a violation is defined as each instance of importation, exportation, manufacturing, distribution, or possession with intent to manufacture or distribute. The bill further reads: "In the case of a distribution, dispensing, or possession with intent to distribute or dispense in violation of...this section at the retail level, up to $1000 per violation. For purposes of this paragraph, the term at the retail level refers to products sold, or held for sale, directly to the consumer for personal use. Each package, container or other separate unit containing an anabolic steroid that is distributed, dispensed, or possessed with intent to distribute or dispense at the retail level in violation...shall be considered a separate violation. " The bill was introduced into the United States House of Representatives during the 113th United States Congress. The President signed the bill into law on December 18, 2014. (en)
agenciesaffected	Department of Health and Human Services United States Department of Justice

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 62 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software